Blood test could identify COVID-19 patients at risk of ‘cytokine storm’ hyperinflammation

Researchers have identified a blood profile that could help identify COVID-19 patients at greatest risk of deterioration and direct them towards trials of specific treatments that could modify their immune systems’ responses.